baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC TUR.OP.END. BULL AMG/ DE000HC4A0N4 /

2024-09-11 9:42:08 AM	Chg.-0.010	Bid9:57:17 AM	Ask9:57:17 AM	Underlying	Strike price	Expiration date	Option type
9.970EUR	-0.10%	9.970 Bid Size: 1,000	10.080 Ask Size: 1,000	Amgen Inc	217.2919 USD	2078-12-31	Call

GlobeNewswire 08-29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 08-28 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...

GlobeNewswire 08-26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials

GlobeNewswire 08-26 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 08-15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 08-12 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08-08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08-08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

TeleTrader 08-07 US closes lower with earnings in focus

TeleTrader 08-07 US turns red, Dow loses more than 200 pts

GlobeNewswire 08-07 89bio Appoints Francis Sarena as Chief Operating Officer

TeleTrader 08-06 Amgen books revenue of $8.4B in Q2, up 20%

TeleTrader 08-06 US extends premarket gains, Dow surges 250 pts

GlobeNewswire 08-05 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors

TeleTrader 08-01 Dow jumps 250 pts as Meta surges more than 10%

GlobeNewswire 08-01 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 07-22 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...

GlobeNewswire 07-09 ImCheck Appoints Stephan Braun as Chief Medical Officer

GlobeNewswire 07-02 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...

GlobeNewswire 07-01 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

GlobeNewswire 06-27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...

GlobeNewswire 06-27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...

GlobeNewswire 06-26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

GlobeNewswire 06-26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer

GlobeNewswire 06-25 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025

UC TUR.OP.END. BULL AMG/ DE000HC4A0N4 /

If you wish to receive reply to your feedback, please provide your email address.